| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 102.24B | 103.85B | 98.22B | 93.12B | 84.35B | 81.18B |
| Gross Profit | 28.90B | 24.99B | 23.35B | 22.12B | 18.15B | 15.94B |
| EBITDA | 13.64B | 13.52B | 12.16B | 11.24B | 8.49B | 6.67B |
| Net Income | 6.04B | 6.06B | 4.75B | 3.77B | 2.21B | -1.75B |
Balance Sheet | ||||||
| Total Assets | 184.42B | 181.61B | 181.29B | 167.90B | 165.15B | 165.69B |
| Cash, Cash Equivalents and Short-Term Investments | 4.94B | 5.42B | 9.67B | 9.33B | 7.38B | 8.25B |
| Total Debt | 84.63B | 79.19B | 80.67B | 79.60B | 82.38B | 85.51B |
| Total Liabilities | 120.59B | 118.43B | 121.96B | 115.12B | 116.76B | 117.94B |
| Stockholders Equity | 63.46B | 62.83B | 59.01B | 52.47B | 48.10B | 47.48B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.57B | 70.79M | 5.88B | 4.62B | -236.70M |
| Operating Cash Flow | 0.00 | 9.10B | 6.37B | 8.36B | 8.73B | 9.25B |
| Investing Cash Flow | 0.00 | -11.26B | -5.63B | -2.49B | -5.15B | -11.92B |
| Financing Cash Flow | 0.00 | -2.69B | -52.65M | -3.71B | -3.86B | 3.91B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥55.82B | 6.43 | ― | 2.97% | -2.75% | -3.17% | |
72 Outperform | ¥306.67B | 8.90 | ― | 2.30% | -1.88% | -9.94% | |
68 Neutral | ¥337.35B | 8.73 | 8.87% | 1.19% | -8.30% | 14.55% | |
66 Neutral | ¥354.85B | 7.48 | ― | 2.26% | 6.13% | -23.73% | |
64 Neutral | ¥649.48B | 8.73 | 8.64% | 1.82% | 3.90% | 5.62% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥132.75B | 16.52 | ― | 1.40% | 4.80% | 30.05% |